David R. Helton

1.3k total citations
22 papers, 1.1k citations indexed

About

David R. Helton is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, David R. Helton has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in David R. Helton's work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (6 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). David R. Helton is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (6 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). David R. Helton collaborates with scholars based in United States and Canada. David R. Helton's co-authors include Mary Jeanne Kallman, Darryle D. Schoepp, James A. Monn, Joseph P. Tizzano, Kurt Rasmussen, Rebecca A. Wright, Bryan G. Johnson, Matthew J. Valli, Craig R. Salhoff and Trevor Howe and has published in prestigious journals such as Brain Research, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

David R. Helton

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Helton United States 14 831 614 207 120 112 22 1.1k
Mary Jeanne Kallman United States 19 967 1.2× 666 1.1× 266 1.3× 147 1.2× 144 1.3× 50 1.5k
Manolo Mugnaini Italy 19 996 1.2× 881 1.4× 164 0.8× 135 1.1× 64 0.6× 28 1.4k
B M Baron United States 15 767 0.9× 575 0.9× 96 0.5× 71 0.6× 162 1.4× 21 1.1k
Hugh J. Herdon United Kingdom 20 790 1.0× 692 1.1× 154 0.7× 74 0.6× 45 0.4× 39 1.2k
Gregory E. Martin United States 20 1.3k 1.5× 870 1.4× 152 0.7× 248 2.1× 130 1.2× 38 1.6k
Jesse Brodkin United States 18 1.4k 1.6× 1.0k 1.7× 232 1.1× 163 1.4× 127 1.1× 20 1.9k
Kazumasa Yamaguchi Japan 21 740 0.9× 582 0.9× 128 0.6× 58 0.5× 61 0.5× 65 1.1k
H Rosengarten United States 18 693 0.8× 488 0.8× 85 0.4× 80 0.7× 63 0.6× 34 1.2k
Penny G. Threlkeld United States 18 752 0.9× 428 0.7× 109 0.5× 105 0.9× 102 0.9× 23 1.2k
Felix Brugger Switzerland 17 794 1.0× 544 0.9× 146 0.7× 208 1.7× 84 0.8× 23 1.1k

Countries citing papers authored by David R. Helton

Since Specialization
Citations

This map shows the geographic impact of David R. Helton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Helton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Helton more than expected).

Fields of papers citing papers by David R. Helton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Helton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Helton. The network helps show where David R. Helton may publish in the future.

Co-authorship network of co-authors of David R. Helton

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Helton. A scholar is included among the top collaborators of David R. Helton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Helton. David R. Helton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lucot, James B., et al.. (2014). The broad-spectrum antiemetic effects ETI-385 result from stimulation of 5-HT1A and 5-HT1D receptors. Experimental Brain Research. 232(8). 2699–2707. 1 indexed citations
2.
Clark, Stewart D., Hans‐Peter Nothacker, Charles D. Blaha, et al.. (2005). Urotensin II acts as a modulator of mesopontine cholinergic neurons. Brain Research. 1059(2). 139–148. 18 indexed citations
3.
Helton, David R., et al.. (2000). Pharmacokinetic Profiles in Rats After Intravenous, Oral, or Dermal Administration of Dapsone. Drug Metabolism and Disposition. 28(8). 925–929. 15 indexed citations
4.
Helton, David R., et al.. (1998). Anxiolytic and Side-Effect Profile of LY354740: A Potent, Highly Selective, Orally Active Agonist for Group II Metabotropic Glutamate Receptors. Journal of Pharmacology and Experimental Therapeutics. 284(2). 651–660. 240 indexed citations
5.
6.
Rasmussen, Kurt, Mary Jeanne Kallman, & David R. Helton. (1997). Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response. Synapse. 27(2). 145–152. 34 indexed citations
7.
Helton, David R., Joseph P. Tizzano, James A. Monn, Darryle D. Schoepp, & Mary Jeanne Kallman. (1997). LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats. Neuropharmacology. 36(11-12). 1511–1516. 77 indexed citations
8.
9.
Iyengar, Satish, Philip A. Hipskind, Donald R. Gehlert, et al.. (1997). LY303870, a Centrally Active Neurokinin-1 Antagonist with a Long Duration of Action. Journal of Pharmacology and Experimental Therapeutics. 280(2). 774–785. 51 indexed citations
10.
Helton, David R., et al.. (1996). Central nervous system characterization of the new cholecystokininB antagonist LY288513. Pharmacology Biochemistry and Behavior. 53(3). 493–502. 29 indexed citations
11.
Rasmussen, Kurt, Janet F. Czachura, Mary Jeanne Kallman, & David R. Helton. (1996). The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle. Neuroreport. 7(5). 1050–1052. 23 indexed citations
12.
Tizzano, Joseph P., Kelly I. Griffey, David R. Helton, et al.. (1996). Agonists and antagonists of metabotropic glutamate receptor subtypes as anticonvulsant agents. Neuropharmacology. 35(6). A31–A31. 1 indexed citations
13.
Rasmussen, Kurt, et al.. (1994). The CCK‐B Antagonist LY288513 Blocks Diazepam‐Withdrawal‐Induced Increases in Auditory Startle Response. Annals of the New York Academy of Sciences. 713(1). 374–376. 8 indexed citations
14.
15.
Rasmussen, Kurt, et al.. (1993). The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle. Neuroreport. 5(2). 154–156. 26 indexed citations
16.
Helton, David R., et al.. (1993). Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity. Psychopharmacology. 113(2). 205–210. 70 indexed citations
17.
18.
Bendele, A.M., Mildred K. Buening, James A. Clemens, et al.. (1993). General pharmacology of loracarbef in animals.. PubMed. 43(1). 60–70. 2 indexed citations
19.
Williams, Paul, et al.. (1991). General pharmacology of a new potent 5-hydroxytryptamine antagonist.. PubMed. 41(3). 189–95.
20.
Williams, Patricia D. & David R. Helton. (1991). The proconvulsive activity of quinolone antibiotics in an animal model. Toxicology Letters. 58(1). 23–28. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Jeanne Kallman Breakdown of academic impact, for papers by Manolo Mugnaini Breakdown of academic impact, for papers by B M Baron Breakdown of academic impact, for papers by Hugh J. Herdon Breakdown of academic impact, for papers by Gregory E. Martin Breakdown of academic impact, for papers by Jesse Brodkin Breakdown of academic impact, for papers by Kazumasa Yamaguchi Breakdown of academic impact, for papers by H Rosengarten Breakdown of academic impact, for papers by Penny G. Threlkeld Breakdown of academic impact, for papers by Felix Brugger
Rankless by CCL
2026